Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates
International Journal of Molecular Sciences · 08.02.2023 · 24 (4) · 3400
DOI: 10.3390/ijms24043400 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.02.2023. Verfasst von Jacopo Gomena und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, Faculty of Science, Eötvös Loránd University, 1117 Budapest, Hungary. Hauptthemen laut MEDLINE: Bombesin, Prostatic Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, European Regional Development Fund (EU and State of Hungary), National Laboratories Excellence program.
Abstract (Originalsprache)
Targeted tumour therapy has proved to be an efficient alternative to overcome the limitations of conventional chemotherapy. Among several receptors upregulated in cancer cells, the gastrin-releasing peptide receptor (GRP-R) has recently emerged as a promising target for cancer imaging, diagnosing and treatment due to its overexpression on cancerous tissues such as breast, prostate, pancreatic and small-cell lung cancer. Herein, we report on the in vitro and in vivo selective delivery of the cytotoxic drug daunorubicin to prostate and breast cancer, by targeting GRP-R. Exploiting many bombesin analogues as homing peptides, including a newly developed peptide, we produced eleven daunorubicin-containing peptide–drug conjugates (PDCs), acting as drug delivery systems to safely reach the tumour environment. Two of our bioconjugates revealed remarkable anti-proliferative activity, an efficient uptake by all three tested human breast and prostate cancer cell lines, high stability in plasma and a prompt release of the drug-containing metabolite by lysosomal enzymes. Moreover, they revealed a safe profile and a consistent reduction of the tumour volume in vivo. In conclusion, we highlight the importance of GRP-R binding PDCs in targeted cancer therapy, with the possibility of further tailoring and optimisation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemistry, Faculty of Science, Eötvös Loránd University, 1117 Budapest, Hungary.
- ELKH-ELTE Research Group of Peptide Chemistry, 1117 Budapest, Hungary.
- Department of Experimental Pharmacology, National Institute of Oncology, 1122 Budapest, Hungary.
- Department of Genetics, Cell and Immunobiology, Semmelweis University, 1089 Budapest, Hungary.
- MTA-ELTE Lendület Ion Mobility Mass Spectrometry Research Group, 1117 Budapest, Hungary.
- Department of Anatomy, Histology and Embryology, Semmelweis University, 1085 Budapest, Hungary.
ORCID-Profile: Jacopo Gomena, Balázs Vári, Beáta Biri-Kovács, Szilvia Bősze, Adina Borbély
Förderung
- National Research, Development and Innovation Office
- European Regional Development Fund (EU and State of Hungary)
- National Laboratories Excellence program
- Hungarian Thematic Excellence Programme
- European Union's Horizon 2020 research and innovation programme
- European Union’s Horizon 2020 research and innovation programme
- National Research, Development and Innovation Office, Hungary
- European Union and the State of Hungary
Zitieren
APA
Gomena, J., Vári, B., Oláh-Szabó, R., Biri-Kovács, B., Bősze, S., Borbély, A., Soós, Á., Ranđelović, I., Tóvári, J., & Mező, G. (2023). Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates. International Journal of Molecular Sciences, 24(4), 3400. https://doi.org/10.3390/ijms24043400
Vancouver
Gomena J, Vári B, Oláh-Szabó R, Biri-Kovács B, Bősze S, Borbély A, et al. Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates. International Journal of Molecular Sciences. 2023;24(4):3400. doi:10.3390/ijms24043400
BibTeX
@article{Gomena2023,
author = {Gomena, Jacopo and Vári, Balázs and Oláh-Szabó, Rita and Biri-Kovács, Beáta and Bősze, Szilvia and Borbély, Adina and Soós, Ádám and Ranđelović, Ivan and Tóvári, József and Mező, Gábor},
title = {Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3400},
doi = {10.3390/ijms24043400}
}
EUVIMED